首页 > 最新文献

Gastrointestinal Tumors最新文献

英文 中文
Coexistence of Gastric Cancer and Multiple Small Gastrointestinal Stromal Tumors: Report of a Unique Case and Review of the Literature. 胃癌与胃肠道多发小间质瘤共存:1例报道及文献复习。
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-02-01 Epub Date: 2018-12-21 DOI: 10.1159/000495178
Helen J Trihia

Background: In recent years, the synchronous occurrence of tumors of different histotypes arising in the same organ has been reported more frequently in the literature. The simultaneous development of adenocarcinoma and gastrointestinal stromal tumor (GIST) has been documented rarely.

Summary: The coexistence of primary gastric adenocarcinoma and GIST has been detected incidentally on gastric mucosa, serosa or occasionally intramurally, at surgery, or gastroscopy for other reasons. We present a case of a 79-year-old male patient who underwent surgery for an advanced gastric carcinoma, where multiple nodules of GIST were incidentally discovered during the work-up of his gastrectomy specimen.

Key message: GISTs range from small "low-risk" tumors to sarcomas. Small GISTs are found incidentally during unrelated surgery or autopsy. Multiple GISTs are extremely rare and usually associated with hereditary diseases.

Practical implications: In any case of gastrointestinal neoplasm, the surgeon and pathologist should be alert to perform a thorough investigation. Our case could provide further awareness and insight into the entity of concurrent tumors.

背景:近年来,不同组织型肿瘤同时发生于同一器官的报道越来越多。腺癌和胃肠道间质瘤(GIST)同时发生的病例很少。摘要:原发性胃腺癌和胃肠道间质瘤的共存在胃粘膜、浆膜上偶然发现,偶尔也会在胃壁内、手术或胃镜检查中发现。我们报告一个79岁的男性病人,他接受了晚期胃癌的手术,在他的胃切除术标本的检查中偶然发现了多个GIST结节。关键信息:gist范围从小的“低风险”肿瘤到肉瘤。小的胃肠道间质瘤是在不相关的手术或尸检中偶然发现的。多发性胃肠道间质瘤极为罕见,通常与遗传性疾病有关。实际意义:在任何情况下胃肠道肿瘤,外科医生和病理学家应警惕进行彻底的调查。我们的病例可以提供进一步的认识和洞察并发肿瘤的实体。
{"title":"Coexistence of Gastric Cancer and Multiple Small Gastrointestinal Stromal Tumors: Report of a Unique Case and Review of the Literature.","authors":"Helen J Trihia","doi":"10.1159/000495178","DOIUrl":"https://doi.org/10.1159/000495178","url":null,"abstract":"<p><strong>Background: </strong>In recent years, the synchronous occurrence of tumors of different histotypes arising in the same organ has been reported more frequently in the literature. The simultaneous development of adenocarcinoma and gastrointestinal stromal tumor (GIST) has been documented rarely.</p><p><strong>Summary: </strong>The coexistence of primary gastric adenocarcinoma and GIST has been detected incidentally on gastric mucosa, serosa or occasionally intramurally, at surgery, or gastroscopy for other reasons. We present a case of a 79-year-old male patient who underwent surgery for an advanced gastric carcinoma, where multiple nodules of GIST were incidentally discovered during the work-up of his gastrectomy specimen.</p><p><strong>Key message: </strong>GISTs range from small \"low-risk\" tumors to sarcomas. Small GISTs are found incidentally during unrelated surgery or autopsy. Multiple GISTs are extremely rare and usually associated with hereditary diseases.</p><p><strong>Practical implications: </strong>In any case of gastrointestinal neoplasm, the surgeon and pathologist should be alert to perform a thorough investigation. Our case could provide further awareness and insight into the entity of concurrent tumors.</p>","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"5 3-4","pages":"63-67"},"PeriodicalIF":1.6,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000495178","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37308432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Adherence to European Polypectomy Guidelines: Retrospective Experience from a Tertiary Irish Hospital. 遵守欧洲息肉切除指南:爱尔兰一家三级医院的回顾性经验。
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-02-01 Epub Date: 2018-11-22 DOI: 10.1159/000494351
Vikrant Parihar, Julia Sopheno-Falco, Pardeep Maheshwari, Neil O'Moran, Vivien Graziadei, Aishling O'Grady Walshe, Orla O'Dwyer, Lakshman Kumar, Sean Fennessy, Niall Breslin, Barbara M Ryan, Deirdre McNamara

Background and study aim: The European guidelines for colorectal cancer screening state that snare resection should remove any polyps ≥5 mm. This study aimed to investigate if these new guidelines are adhered to in clinical practice.

Patients and methods: This study consists of patients who underwent colonoscopies in Tallaght Hospital, Dublin (AMNCH), between 2012 and 2015. The size of the polyp, the method of removal, and the subspecialty and grade of the endoscopists were all recorded.

Results: 6,000 colonoscopies were reviewed and 687 (12.5%) of these patients were found to have polyps. In 655 (95%) colonoscopies, the caecum was positively identified. In all, 371 (54%) of the polyps detected were < 5 mm; resection via forceps was carried out in n405 cases (59%). Overall, 16% (n = 45) of the polyps > 5 mm underwent resection with forceps, showing that the new European guidelines are not being tightly adhered to.

Conclusions: This study found an 84% compliance with polypectomy resection guidelines which is an improvement on previous studies. However, endoscopist grade significantly affected compliance and may reflect overall competency, highlighting the need for specific training in snare polypectomy techniques.

背景与研究目的:欧洲结直肠癌筛查指南指出圈套切除术应切除≥5mm的息肉。本研究旨在探讨这些新指南是否在临床实践中得到遵守。患者和方法:本研究包括2012年至2015年间在都柏林Tallaght医院(AMNCH)接受结肠镜检查的患者。息肉的大小、切除方法、内镜医师的亚专科和等级都被记录下来。结果:回顾6000例结肠镜检查,其中687例(12.5%)发现息肉。在655例(95%)结肠镜检查中,盲肠被确诊。其中< 5mm息肉371例(54%);n405例(59%)采用钳路切除。总的来说,16% (n = 45) > 5mm的息肉用钳切除,这表明新的欧洲指南没有得到严格遵守。结论:本研究发现84%的患者符合息肉切除术指南,这是以往研究的改进。然而,内窥镜医师的等级显著影响依从性,并可能反映整体能力,强调需要在圈套息肉切除术技术方面进行专门培训。
{"title":"Adherence to European Polypectomy Guidelines: Retrospective Experience from a Tertiary Irish Hospital.","authors":"Vikrant Parihar,&nbsp;Julia Sopheno-Falco,&nbsp;Pardeep Maheshwari,&nbsp;Neil O'Moran,&nbsp;Vivien Graziadei,&nbsp;Aishling O'Grady Walshe,&nbsp;Orla O'Dwyer,&nbsp;Lakshman Kumar,&nbsp;Sean Fennessy,&nbsp;Niall Breslin,&nbsp;Barbara M Ryan,&nbsp;Deirdre McNamara","doi":"10.1159/000494351","DOIUrl":"https://doi.org/10.1159/000494351","url":null,"abstract":"<p><strong>Background and study aim: </strong>The European guidelines for colorectal cancer screening state that snare resection should remove any polyps ≥5 mm. This study aimed to investigate if these new guidelines are adhered to in clinical practice.</p><p><strong>Patients and methods: </strong>This study consists of patients who underwent colonoscopies in Tallaght Hospital, Dublin (AMNCH), between 2012 and 2015. The size of the polyp, the method of removal, and the subspecialty and grade of the endoscopists were all recorded.</p><p><strong>Results: </strong>6,000 colonoscopies were reviewed and 687 (12.5%) of these patients were found to have polyps. In 655 (95%) colonoscopies, the caecum was positively identified. In all, 371 (54%) of the polyps detected were < 5 mm; resection via forceps was carried out in <i>n</i>405 cases (59%). Overall, 16% (<i>n</i> = 45) of the polyps > 5 mm underwent resection with forceps, showing that the new European guidelines are not being tightly adhered to.</p><p><strong>Conclusions: </strong>This study found an 84% compliance with polypectomy resection guidelines which is an improvement on previous studies. However, endoscopist grade significantly affected compliance and may reflect overall competency, highlighting the need for specific training in snare polypectomy techniques.</p>","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"5 3-4","pages":"82-89"},"PeriodicalIF":1.6,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000494351","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37321355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Low Incidence of Pelvic Sepsis after Hartmann's Procedure: Radiation Therapy May Be a Risk Factor. 哈特曼手术后盆腔败血症的低发病率:放射治疗可能是一个危险因素。
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-02-01 Epub Date: 2018-11-05 DOI: 10.1159/000493526
Carmela Wetterhall, Elin Mariusdottir, Claire Hall, Fredrik Jörgren, Pamela Buchwald

Purpose: Hartmann's procedure is a well-established alternative in colorectal surgery when a primary anastomosis is contraindicated. However, the rectal remnant may cause complications. This study was designed to investigate the occurrence of pelvic sepsis after Hartmann's procedure and identify possible risk factors.

Methods: All patients who underwent Hartmann's procedure between 2005 and 2012 were identified by the in-hospital registry. Information about pelvic sepsis and potential preoperative, perioperative, and postoperative risk factors was obtained by review of the medical records.

Results: 172 patients were identified (97 females); they were aged 74 ± 11 years. Surgery was performed due to cancer (49%) or diverticulitis (35%) and other benign disease (16%). Rectal transection was carried out anywhere between the pelvic floor and the promontory. Pelvic sepsis developed in 6.4% (11/172) of patients. Pelvic sepsis was associated with preoperative radiotherapy (p = 0.03) and Hinchey grade III and IV (p = 0.02) in those patients who underwent Hartmann's procedure for diverticular disease.

Conclusion: Hartmann's procedure is a safe operation when an anastomosis is contraindicated since the incidence of pelvic sepsis is low. Preoperative radiotherapy and Hinchey grade III and IV may be risk factors for the development of pelvic sepsis.

目的:Hartmann手术是结直肠手术中一段吻合术禁忌时的一种成熟的替代方法。然而,直肠残余可能引起并发症。本研究旨在调查Hartmann手术后盆腔败血症的发生情况,并确定可能的危险因素。方法:所有2005年至2012年间接受哈特曼手术的患者通过住院登记进行识别。通过查阅医疗记录获得盆腔败血症和潜在的术前、围手术期和术后危险因素的信息。结果:共发现172例患者(女性97例);年龄74±11岁。手术是由于癌症(49%)或憩室炎(35%)和其他良性疾病(16%)。直肠横断在骨盆底和海岬之间的任何地方进行。6.4%(11/172)的患者发生盆腔败血症。盆腔败血症与术前放疗相关(p = 0.03),在接受Hartmann手术治疗憩室疾病的患者中与Hinchey III级和IV级相关(p = 0.02)。结论:由于盆腔败血症发生率低,在吻合术禁忌时,Hartmann手术是一种安全的手术。术前放疗和Hinchey III级和IV级可能是发生盆腔败血症的危险因素。
{"title":"Low Incidence of Pelvic Sepsis after Hartmann's Procedure: Radiation Therapy May Be a Risk Factor.","authors":"Carmela Wetterhall,&nbsp;Elin Mariusdottir,&nbsp;Claire Hall,&nbsp;Fredrik Jörgren,&nbsp;Pamela Buchwald","doi":"10.1159/000493526","DOIUrl":"https://doi.org/10.1159/000493526","url":null,"abstract":"<p><strong>Purpose: </strong>Hartmann's procedure is a well-established alternative in colorectal surgery when a primary anastomosis is contraindicated. However, the rectal remnant may cause complications. This study was designed to investigate the occurrence of pelvic sepsis after Hartmann's procedure and identify possible risk factors.</p><p><strong>Methods: </strong>All patients who underwent Hartmann's procedure between 2005 and 2012 were identified by the in-hospital registry. Information about pelvic sepsis and potential preoperative, perioperative, and postoperative risk factors was obtained by review of the medical records.</p><p><strong>Results: </strong>172 patients were identified (97 females); they were aged 74 ± 11 years. Surgery was performed due to cancer (49%) or diverticulitis (35%) and other benign disease (16%). Rectal transection was carried out anywhere between the pelvic floor and the promontory. Pelvic sepsis developed in 6.4% (11/172) of patients. Pelvic sepsis was associated with preoperative radiotherapy (<i>p</i> = 0.03) and Hinchey grade III and IV (<i>p</i> = 0.02) in those patients who underwent Hartmann's procedure for diverticular disease.</p><p><strong>Conclusion: </strong>Hartmann's procedure is a safe operation when an anastomosis is contraindicated since the incidence of pelvic sepsis is low. Preoperative radiotherapy and Hinchey grade III and IV may be risk factors for the development of pelvic sepsis.</p>","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"5 3-4","pages":"77-81"},"PeriodicalIF":1.6,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000493526","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37308434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Comparison of Different Techniques of Pancreatic Stump Management in Robot-Assisted Pancreaticoduodenectomy. 机器人辅助胰十二指肠切除术中胰腺残端处理不同技术的比较。
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-02-01 Epub Date: 2018-08-27 DOI: 10.1159/000489777
Raquel Gonzalez-Heredia, Samarth Durgam, Mario Masrur, Luis Fernando Gonzalez-Ciccarelli, Antonio Gangemi, Francesco M Bianco, Pier C Giulianotti

Background: Various technical improvements have decreased the morbidity and mortality after pancreaticoduodenectomy. However, postoperative pancreatic fistula (POPF) is the most feared complication, and the ideal technique for pancreatic reconstruction is undetermined. The aim of this study was to identify the risk factors and incidence of POPF with different types of pancreatic stump management after robot-assisted pancreaticoduodenectomy (RAPD).

Materials and methods: This study is a retrospective review of consecutive patients who underwent RAPD at the University of Illinois Hospital and Health Sciences System between September 2007 and January 2016. The cohort was divided based on the type of pancreatic stump management: pancreatic duct occlusion with cyanoacrylate glue (CG), pancreaticojejunostomy (PJ), posterior pancreaticogastrostomy (PPG), and transgastric pancreaticogastrostomy (TPG).

Results: The cohort included 69 patients: pancreatic duct occlusion with CG (n = 18), PJ (n = 12), PPG (n = 11), and TPG (n = 28). Pancreatic duct diameter < 3 mm and duct occlusion with CG were identified as risk factors for POPF (p < 0.05). The incidence of POPF was lower when TPG and PJ were performed (p < 0.001).

Conclusions: Reconstruction with PJ and TPG had better results compared to pancreatic duct occlusion with CG and PPG. However, TPG was the technique of choice and showed comparable results to PJ.

背景:各种技术的进步降低了胰十二指肠切除术后的发病率和死亡率。然而,术后胰瘘(POPF)是最可怕的并发症,理想的胰腺重建技术尚未确定。本研究的目的是确定机器人辅助胰十二指肠切除术(RAPD)后不同胰残端处理方式下POPF的危险因素和发生率。材料和方法:本研究是对2007年9月至2016年1月在伊利诺伊大学医院和健康科学系统接受RAPD的连续患者的回顾性研究。该队列根据胰腺残端处理类型分为:用氰基丙烯酸酯胶封堵胰管(CG)、胰空肠吻合术(PJ)、后胰胃造口术(PPG)和经胃胰胃造口术(TPG)。结果:纳入69例患者:胰管阻塞合并CG (n = 18)、PJ (n = 12)、PPG (n = 11)和TPG (n = 28)。胰管直径< 3mm和胰管阻塞合并CG是发生POPF的危险因素(p < 0.05)。行TPG和PJ时,POPF的发生率较低(p < 0.001)。结论:与CG和PPG封堵胰管相比,PJ和TPG重建胰管效果更好。然而,TPG是首选的技术,其结果与PJ相当。
{"title":"Comparison of Different Techniques of Pancreatic Stump Management in Robot-Assisted Pancreaticoduodenectomy.","authors":"Raquel Gonzalez-Heredia,&nbsp;Samarth Durgam,&nbsp;Mario Masrur,&nbsp;Luis Fernando Gonzalez-Ciccarelli,&nbsp;Antonio Gangemi,&nbsp;Francesco M Bianco,&nbsp;Pier C Giulianotti","doi":"10.1159/000489777","DOIUrl":"https://doi.org/10.1159/000489777","url":null,"abstract":"<p><strong>Background: </strong>Various technical improvements have decreased the morbidity and mortality after pancreaticoduodenectomy. However, postoperative pancreatic fistula (POPF) is the most feared complication, and the ideal technique for pancreatic reconstruction is undetermined. The aim of this study was to identify the risk factors and incidence of POPF with different types of pancreatic stump management after robot-assisted pancreaticoduodenectomy (RAPD).</p><p><strong>Materials and methods: </strong>This study is a retrospective review of consecutive patients who underwent RAPD at the University of Illinois Hospital and Health Sciences System between September 2007 and January 2016. The cohort was divided based on the type of pancreatic stump management: pancreatic duct occlusion with cyanoacrylate glue (CG), pancreaticojejunostomy (PJ), posterior pancreaticogastrostomy (PPG), and transgastric pancreaticogastrostomy (TPG).</p><p><strong>Results: </strong>The cohort included 69 patients: pancreatic duct occlusion with CG (<i>n</i> = 18), PJ (<i>n</i> = 12), PPG (<i>n</i> = 11), and TPG (<i>n</i> = 28). Pancreatic duct diameter < 3 mm and duct occlusion with CG were identified as risk factors for POPF (<i>p</i> < 0.05). The incidence of POPF was lower when TPG and PJ were performed (<i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Reconstruction with PJ and TPG had better results compared to pancreatic duct occlusion with CG and PPG. However, TPG was the technique of choice and showed comparable results to PJ.</p>","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"5 3-4","pages":"68-76"},"PeriodicalIF":1.6,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000489777","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37308433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Front & Back Matter 正面和背面事项
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-02-01 DOI: 10.1159/000498928
Jing-yuan Fang, P. Malfertheiner, P. Malfertheiner
{"title":"Front & Back Matter","authors":"Jing-yuan Fang, P. Malfertheiner, P. Malfertheiner","doi":"10.1159/000498928","DOIUrl":"https://doi.org/10.1159/000498928","url":null,"abstract":"","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"5 1","pages":""},"PeriodicalIF":1.6,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49361088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing the Diagnostic Role of Alpha-Fetoprotein and Abdominal Ultrasound by Adding Overexpressed Blood mRNA Matrix Metalloproteinase-12 for Diagnosis of HCV-Related Hepatocellular Carcinoma. 甲胎蛋白及腹部超声添加过表达血mRNA基质金属蛋白酶-12对丙型肝炎相关肝癌的诊断价值
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-02-01 Epub Date: 2019-01-09 DOI: 10.1159/000495838
Esam Elshimi, Mostafa Abdel-Samed Mostafa Sakr, Wesam Saber Morad, Lobna Mohammad

Background and aims: Matrix metalloproteinase-12 (MMP-12) is involved in tumor invasiveness and metastasis and significantly overexpressed in hepatocellular carcinoma (HCC) tissues. We aimed to investigate the diagnostic and prognostic value of blood mRNA MMP-12 overexpression in patients with HCC.

Patients and methods: From January 2017 to June 2017, 100 patients with HCC (HCV-related cirrhosis) and 100 patients with HCV-related cirrhosis (without HCC) were included in this study. All patients were subjected to triphasic CT abdomen when indicated, liver profile, alpha-fetoprotein (AFP), and molecular characterization of metalloproteinase-12 expression.

Results: There were no statistically significant differences between both groups regarding CBC parameters and liver profile (p value > 0.05). There was a statistically significant difference between patients with and without HCC regarding blood mRNA MMP-12 overexpression (p value < 0.01), blood mRNA MMP-12, and/or AFP (sensitivity 84.0%, specificity 60.0%, PPV 51.2%, and NPP 88.2%). The accuracy of mRNA MMP-12 and/or AFP in detection of HCC was 68.0%.

Conclusion: Blood mRNA MMP-12 has a good sensitivity and a bad specificity but is accurate in HCC diagnosis. Adding blood mRNA MMP-12 to AFP optimizes the current screening program to improve early diagnosis of HCC and hence better prognosis.

背景与目的:基质金属蛋白酶-12 (Matrix metalloproteinase-12, MMP-12)在肝细胞癌(HCC)组织中参与肿瘤的侵袭和转移,并显著过表达。我们旨在探讨血液mRNA MMP-12过表达在HCC患者中的诊断和预后价值。患者和方法:2017年1月至2017年6月,本研究纳入100例HCC (hcv相关肝硬化)患者和100例hcv相关肝硬化(非HCC)患者。所有患者均接受腹部三期CT检查,检查肝脏、甲胎蛋白(AFP)和金属蛋白酶-12表达的分子特征。结果:两组患者CBC指标及肝脏特征比较,差异均无统计学意义(p值> 0.05)。HCC患者与非HCC患者在血液mRNA MMP-12过表达(p值< 0.01)、血液mRNA MMP-12和/或AFP方面差异有统计学意义(敏感性84.0%,特异性60.0%,PPV 51.2%, NPP 88.2%)。mRNA MMP-12和/或AFP检测HCC的准确率为68.0%。结论:血液mRNA MMP-12具有良好的敏感性和较差的特异性,但对HCC的诊断是准确的。在甲胎蛋白中加入血液mRNA MMP-12可以优化目前的筛查方案,提高HCC的早期诊断,从而改善预后。
{"title":"Optimizing the Diagnostic Role of Alpha-Fetoprotein and Abdominal Ultrasound by Adding Overexpressed Blood mRNA Matrix Metalloproteinase-12 for Diagnosis of HCV-Related Hepatocellular Carcinoma.","authors":"Esam Elshimi,&nbsp;Mostafa Abdel-Samed Mostafa Sakr,&nbsp;Wesam Saber Morad,&nbsp;Lobna Mohammad","doi":"10.1159/000495838","DOIUrl":"https://doi.org/10.1159/000495838","url":null,"abstract":"<p><strong>Background and aims: </strong>Matrix metalloproteinase-12 (MMP-12) is involved in tumor invasiveness and metastasis and significantly overexpressed in hepatocellular carcinoma (HCC) tissues. We aimed to investigate the diagnostic and prognostic value of blood mRNA MMP-12 overexpression in patients with HCC.</p><p><strong>Patients and methods: </strong>From January 2017 to June 2017, 100 patients with HCC (HCV-related cirrhosis) and 100 patients with HCV-related cirrhosis (without HCC) were included in this study. All patients were subjected to triphasic CT abdomen when indicated, liver profile, alpha-fetoprotein (AFP), and molecular characterization of metalloproteinase-12 expression.</p><p><strong>Results: </strong>There were no statistically significant differences between both groups regarding CBC parameters and liver profile (<i>p</i> value > 0.05). There was a statistically significant difference between patients with and without HCC regarding blood mRNA MMP-12 overexpression (<i>p</i> value < 0.01), blood mRNA MMP-12, and/or AFP (sensitivity 84.0%, specificity 60.0%, PPV 51.2%, and NPP 88.2%). The accuracy of mRNA MMP-12 and/or AFP in detection of HCC was 68.0%.</p><p><strong>Conclusion: </strong>Blood mRNA MMP-12 has a good sensitivity and a bad specificity but is accurate in HCC diagnosis. Adding blood mRNA MMP-12 to AFP optimizes the current screening program to improve early diagnosis of HCC and hence better prognosis.</p>","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"5 3-4","pages":"100-108"},"PeriodicalIF":1.6,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000495838","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37321357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Eye Opener to EtOH Ablation for Juxta-Cardiac Hepatocellular Carcinoma. EtOH消融治疗心旁肝细胞癌的疗效观察。
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-02-01 Epub Date: 2019-01-11 DOI: 10.1159/000495135
Erik Soule, Sanjay Lamsal, Chandana Lall, Jerry Matteo

Background: Hepatocellular carcinoma (HCC) is notoriously refractory to systemic chemotherapy, mandating an interventional approach. Mortality may be avoided by neutralizing rapidly growing tumors that approach the heart and major vessels. When the risk/benefit ratio of surgery is unacceptable, percutaneous ablation can achieve remarkable results. High volumes of flowing blood adjacent to the treatment area may impact the ability to reliably achieve an adequate ablation margin for modalities that rely on extreme temperatures to destroy malignant cells. Ethanol ablation is safe, efficacious, and unaffected by this "thermal sink" effect. This report describes a juxta-cardiac (JC) HCC in segment 4a measuring 35 × 26 mm, which exhibited rapid growth until it was abutting the pericardium and 7.5 mm from the chamber of the right ventricle (RV).

Methods: One 21-gauge needle was inserted using direct CT fluoroscopy into the center of the hepatic mass. In order to confirm the position of the needle, 0.5 mL of diluted Visipaque was injected. Then, under CT fluoroscopy guidance, a mixture of 1 mL of Ethiodol and 10 mL of 98% dehydrated alcohol was slowly injected into the mass.

Results: Repeat CT scan 1 month post-ablation demonstrated decreased arterial enhancement and dense Ethiodol throughout the tumor consistent with ablation. Tumor size decreased to 30 × 23 mm with a distance of 12.4 mm from the chamber of the RV.

Conclusion: Pericardial involvement or large vessels near the treatment area may limit the use of thermal ablation techniques for JC HCC. Percutaneous, intratumoral ethanol injection provides safe and effective alternative that is not subject to the "thermal sink" effect.

背景:肝细胞癌(HCC)是出了名的难以接受全身化疗,因此必须采用介入治疗方法。通过中和接近心脏和主要血管的快速生长的肿瘤,可以避免死亡。当手术的风险/收益比不能接受时,经皮消融可以取得显著的效果。治疗区域附近的大量流动血液可能会影响依靠极端温度来摧毁恶性细胞的模式可靠地获得足够的消融边缘的能力。乙醇消融是安全、有效的,并且不受这种“热沉”效应的影响。本报告描述了一个位于4a节段的近心(JC) HCC,尺寸为35 × 26 mm,表现出快速生长,直到靠近心包和距右心室(RV) 7.5 mm。方法:采用直接CT透视将一根21号针插入肝肿块中心。为了确认针头的位置,注射0.5 mL稀释Visipaque。然后在CT透视引导下,将1ml乙醇与10ml 98%脱水酒精的混合物缓慢注入肿块。结果:消融后1个月的重复CT扫描显示动脉增强减弱,整个肿瘤呈致密的硫噻酚,与消融一致。肿瘤大小缩小至30 × 23 mm,距右心室12.4 mm。结论:累及心包或治疗区附近的大血管可能限制热消融技术在JC型HCC中的应用。经皮、瘤内乙醇注射提供了安全有效的替代方法,不受“热沉”效应的影响。
{"title":"Eye Opener to EtOH Ablation for Juxta-Cardiac Hepatocellular Carcinoma.","authors":"Erik Soule,&nbsp;Sanjay Lamsal,&nbsp;Chandana Lall,&nbsp;Jerry Matteo","doi":"10.1159/000495135","DOIUrl":"https://doi.org/10.1159/000495135","url":null,"abstract":"<p><strong>Background: </strong>Hepatocellular carcinoma (HCC) is notoriously refractory to systemic chemotherapy, mandating an interventional approach. Mortality may be avoided by neutralizing rapidly growing tumors that approach the heart and major vessels. When the risk/benefit ratio of surgery is unacceptable, percutaneous ablation can achieve remarkable results. High volumes of flowing blood adjacent to the treatment area may impact the ability to reliably achieve an adequate ablation margin for modalities that rely on extreme temperatures to destroy malignant cells. Ethanol ablation is safe, efficacious, and unaffected by this \"thermal sink\" effect. This report describes a juxta-cardiac (JC) HCC in segment 4a measuring 35 × 26 mm, which exhibited rapid growth until it was abutting the pericardium and 7.5 mm from the chamber of the right ventricle (RV).</p><p><strong>Methods: </strong>One 21-gauge needle was inserted using direct CT fluoroscopy into the center of the hepatic mass. In order to confirm the position of the needle, 0.5 mL of diluted Visipaque was injected. Then, under CT fluoroscopy guidance, a mixture of 1 mL of Ethiodol and 10 mL of 98% dehydrated alcohol was slowly injected into the mass.</p><p><strong>Results: </strong>Repeat CT scan 1 month post-ablation demonstrated decreased arterial enhancement and dense Ethiodol throughout the tumor consistent with ablation. Tumor size decreased to 30 × 23 mm with a distance of 12.4 mm from the chamber of the RV.</p><p><strong>Conclusion: </strong>Pericardial involvement or large vessels near the treatment area may limit the use of thermal ablation techniques for JC HCC. Percutaneous, intratumoral ethanol injection provides safe and effective alternative that is not subject to the \"thermal sink\" effect.</p>","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"5 3-4","pages":"109-116"},"PeriodicalIF":1.6,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000495135","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37321358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
High Serum CA19-9 Concentration Predicts Poor Prognosis in Elderly Patients with Stage IV Colorectal Cancer. 高血清CA19-9浓度预测老年癌症IV期结直肠癌患者预后不良。
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-02-01 Epub Date: 2019-01-24 DOI: 10.1159/000493793
Eiji Hidaka, Chiyo Maeda, Kenta Nakahara, Kunihiko Wakamura, Yasuhiro Ishiyama, Shoji Shimada, Junichi Seki, Yojiro Takano, Sonoko Oae, Yuta Enami, Naruhiko Sawada, Fumio Ishida, Shin-Ei Kudo

Background/aim: The optimal treatment strategy for elderly patients with stage IV colorectal cancer (CRC) remains controversial due to limited research data. The purpose of this study was to evaluate treatment results and to clarify the prognostic factors, especially poor prognosis factors, in elderly patients with stage IV CRC.

Methods: We retrospectively reviewed the data of 82 elderly patients (aged ≥75 years) with stage IV CRC who underwent surgical treatment at our hospital between April 2001 and March 2017. Factors that affected prognosis and the ability to undergo treatment were analyzed via multivariate analysis.

Results: The median overall survival (OS) in the patients with high pretreatment serum carbohydrate antigen 19-9 (CA19-9) concentration (> 370 U/mL) was significantly worse than in those with lower serum CA19-9 concentration (0-370 U/mL) (8.5 vs. 19.2 months, p = 0.0059). In univariate analysis, age (≥80 years) (p = 0.014), performance status of 1-3 (p = 0.028), and high pretreatment serum CA19-9 concentration (p = 0.014) were significant prognostic factors for poor OS. By contrast, resection of the primary tumor (p = 0.024), chemotherapy (p < 0.0001), and resection of distant metastasis (p = 0.0005) were significant prognostic factors for favorable OS. Multivariate analysis showed that a high pretreatment serum CA19-9 concentration was an independent prognostic factor for poor OS (p = 0.01). Meanwhile, resection of the primary tumor (p = 0.033), chemotherapy (p < 0.0001), and resection of distant metastasis (p = 0.0008) were prognostic factors for favorable OS.

Conclusions: A high pretreatment serum CA19-9 concentration (> 370 U/mL) was a reliable predictive factor for poor prognosis, and aggressive treatments should be performed carefully in these patients. Moreover, various treatments, including surgery and chemotherapy, might improve OS in elderly patients with stage IV CRC.

背景/目的:由于研究数据有限,老年癌症IV期患者的最佳治疗策略仍然存在争议。本研究的目的是评估老年IV期CRC患者的治疗结果,并阐明其预后因素,尤其是不良预后因素。方法:我们回顾性回顾了2001年4月至2017年3月在我院接受手术治疗的82名年龄≥75岁的老年IV期结直肠癌患者的数据。通过多变量分析分析影响预后和接受治疗能力的因素。结果:预处理血清CA19-9浓度高(>370U/mL)的患者的中位总生存率(OS)显著低于血清CA19-9%浓度低(0-370U/mL,8.5个月vs.19.2个月,p=0.0059)。在单变量分析中,年龄(≥80岁)(p=0.014)、1-3岁的工作状态(p=0.028),高预处理血清CA19-9浓度(p=0.014)是OS不良的重要预后因素。相比之下,原发肿瘤切除(p=0.024)、化疗(p<0.0001)和远处转移切除(p=0.0005)是OS良好的重要预后因素。多因素分析显示,治疗前血清CA19-9浓度高是OS不良的独立预后因素(p=0.01),结论:高预处理血清CA19-9浓度(>370U/mL)是预后不良的可靠预测因素,对这些患者应谨慎进行积极治疗。此外,包括手术和化疗在内的各种治疗可能会改善老年IV期CRC患者的OS。
{"title":"High Serum CA19-9 Concentration Predicts Poor Prognosis in Elderly Patients with Stage IV Colorectal Cancer.","authors":"Eiji Hidaka,&nbsp;Chiyo Maeda,&nbsp;Kenta Nakahara,&nbsp;Kunihiko Wakamura,&nbsp;Yasuhiro Ishiyama,&nbsp;Shoji Shimada,&nbsp;Junichi Seki,&nbsp;Yojiro Takano,&nbsp;Sonoko Oae,&nbsp;Yuta Enami,&nbsp;Naruhiko Sawada,&nbsp;Fumio Ishida,&nbsp;Shin-Ei Kudo","doi":"10.1159/000493793","DOIUrl":"10.1159/000493793","url":null,"abstract":"<p><strong>Background/aim: </strong>The optimal treatment strategy for elderly patients with stage IV colorectal cancer (CRC) remains controversial due to limited research data. The purpose of this study was to evaluate treatment results and to clarify the prognostic factors, especially poor prognosis factors, in elderly patients with stage IV CRC.</p><p><strong>Methods: </strong>We retrospectively reviewed the data of 82 elderly patients (aged ≥75 years) with stage IV CRC who underwent surgical treatment at our hospital between April 2001 and March 2017. Factors that affected prognosis and the ability to undergo treatment were analyzed via multivariate analysis.</p><p><strong>Results: </strong>The median overall survival (OS) in the patients with high pretreatment serum carbohydrate antigen 19-9 (CA19-9) concentration (> 370 U/mL) was significantly worse than in those with lower serum CA19-9 concentration (0-370 U/mL) (8.5 vs. 19.2 months, <i>p</i> = 0.0059). In univariate analysis, age (≥80 years) (<i>p</i> = 0.014), performance status of 1-3 (<i>p</i> = 0.028), and high pretreatment serum CA19-9 concentration (<i>p</i> = 0.014) were significant prognostic factors for poor OS. By contrast, resection of the primary tumor (<i>p</i> = 0.024), chemotherapy (<i>p</i> < 0.0001), and resection of distant metastasis (<i>p</i> = 0.0005) were significant prognostic factors for favorable OS. Multivariate analysis showed that a high pretreatment serum CA19-9 concentration was an independent prognostic factor for poor OS (<i>p</i> = 0.01). Meanwhile, resection of the primary tumor (<i>p</i> = 0.033), chemotherapy (<i>p</i> < 0.0001), and resection of distant metastasis (<i>p</i> = 0.0008) were prognostic factors for favorable OS.</p><p><strong>Conclusions: </strong>A high pretreatment serum CA19-9 concentration (> 370 U/mL) was a reliable predictive factor for poor prognosis, and aggressive treatments should be performed carefully in these patients. Moreover, various treatments, including surgery and chemotherapy, might improve OS in elderly patients with stage IV CRC.</p>","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"5 3-4","pages":"117-124"},"PeriodicalIF":1.6,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000493793","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37321359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Contents Vol. 5, 2018 目录2018年第5卷
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-02-01 DOI: 10.1159/000496962
P. Malfertheiner, G. Rogler, Jianqiu Sheng, J. Sollano, Ming-Rong Wang, B. Wiedenmann, Kaichun Wu, P. Malfertheiner
{"title":"Contents Vol. 5, 2018","authors":"P. Malfertheiner, G. Rogler, Jianqiu Sheng, J. Sollano, Ming-Rong Wang, B. Wiedenmann, Kaichun Wu, P. Malfertheiner","doi":"10.1159/000496962","DOIUrl":"https://doi.org/10.1159/000496962","url":null,"abstract":"","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"5 1","pages":"I - IV"},"PeriodicalIF":1.6,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000496962","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45190241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three-Dimensional Remnant Pancreatic Volumetry Predicts Postoperative Pancreatic Fistula in Pancreatic Cancer Patients after Pancreaticoduodenectomy. 三维剩余胰腺容量预测胰腺癌患者胰十二指肠切除术后胰瘘。
IF 1.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2019-02-01 Epub Date: 2018-12-12 DOI: 10.1159/000495406
Ryoichi Miyamoto, Yukio Oshiro, Naoki Sano, Satoshi Inagawa, Nobuhiro Ohkohchi

Background: Postoperative pancreatic fistula (POPF) is a serious complication that can occur following pancreaticoduodenectomy (PD). Recent studies suggest that remnant pancreatic volume (RPV) values from preoperative multidetector computed tomography (MDCT) are highly predictive of POPF. We performed three-dimensional (3D) surgical simulation of PD including RPV measurements. The aim of this study was to determine whether 3D-measured RPV is predictive of POPF after PD.

Methods: We used the SYNAPSE VINCENT® medical imaging system (Fujifilm Medical Co., Ltd., Tokyo, Japan) to construct 3D images after integrating MDCT and magnetic resonance cholangiopancreatography images. RPV was measured using this 3D image, which simulated actual intraoperative pancreatic parenchymal remnant volume. Ninety-one patients who underwent PD were retrospectively enrolled. Using multivariate analysis, RPV and other well-known POPF risk factors were independently assessed.

Results: Multivariate analysis identified high RPV values (hazard ratio [HR] = 8.41, p = 0.01), pancreatic duct diameter < 3.0 mm (HR = 5.48, p < 0.01), no pathological fibrosis (HR = 3.41, p < 0.01), and body mass index > 25 kg/m2 (HR = 1.53, p = 0.02) as independent risk factors for POPF.

Conclusion: The present study indicates that preoperative 3D-measured RPV is predictive of POPF after PD.

背景:术后胰瘘(POPF)是胰十二指肠切除术(PD)后可能发生的严重并发症。最近的研究表明,术前多探测器计算机断层扫描(MDCT)的残余胰腺体积(RPV)值可以高度预测POPF。我们进行了PD的三维(3D)手术模拟,包括RPV测量。本研究的目的是确定3d测量的RPV是否可以预测PD后的POPF。方法:采用SYNAPSE VINCENT®医学成像系统(Fujifilm medical Co., Ltd, Tokyo, Japan),整合MDCT和磁共振胆管造影图像,构建三维图像。使用3D图像测量RPV,模拟实际术中胰腺实质残余体积。91例PD患者回顾性入选。采用多变量分析,独立评估RPV和其他已知的POPF危险因素。结果:多因素分析发现,高RPV值(危险比[HR] = 8.41, p = 0.01)、胰管直径< 3.0 mm (HR = 5.48, p < 0.01)、无病理性纤维化(HR = 3.41, p < 0.01)、体重指数> 25 kg/m2 (HR = 1.53, p = 0.02)是POPF的独立危险因素。结论:本研究提示术前3d测量RPV可预测PD后POPF的发生。
{"title":"Three-Dimensional Remnant Pancreatic Volumetry Predicts Postoperative Pancreatic Fistula in Pancreatic Cancer Patients after Pancreaticoduodenectomy.","authors":"Ryoichi Miyamoto,&nbsp;Yukio Oshiro,&nbsp;Naoki Sano,&nbsp;Satoshi Inagawa,&nbsp;Nobuhiro Ohkohchi","doi":"10.1159/000495406","DOIUrl":"https://doi.org/10.1159/000495406","url":null,"abstract":"<p><strong>Background: </strong>Postoperative pancreatic fistula (POPF) is a serious complication that can occur following pancreaticoduodenectomy (PD). Recent studies suggest that remnant pancreatic volume (RPV) values from preoperative multidetector computed tomography (MDCT) are highly predictive of POPF. We performed three-dimensional (3D) surgical simulation of PD including RPV measurements. The aim of this study was to determine whether 3D-measured RPV is predictive of POPF after PD.</p><p><strong>Methods: </strong>We used the SYNAPSE VINCENT® medical imaging system (Fujifilm Medical Co., Ltd., Tokyo, Japan) to construct 3D images after integrating MDCT and magnetic resonance cholangiopancreatography images. RPV was measured using this 3D image, which simulated actual intraoperative pancreatic parenchymal remnant volume. Ninety-one patients who underwent PD were retrospectively enrolled. Using multivariate analysis, RPV and other well-known POPF risk factors were independently assessed.</p><p><strong>Results: </strong>Multivariate analysis identified high RPV values (hazard ratio [HR] = 8.41, <i>p</i> = 0.01), pancreatic duct diameter < 3.0 mm (HR = 5.48, <i>p</i> < 0.01), no pathological fibrosis (HR = 3.41, <i>p</i> < 0.01), and body mass index > 25 kg/m<sup>2</sup> (HR = 1.53, <i>p</i> = 0.02) as independent risk factors for POPF.</p><p><strong>Conclusion: </strong>The present study indicates that preoperative 3D-measured RPV is predictive of POPF after PD.</p>","PeriodicalId":45017,"journal":{"name":"Gastrointestinal Tumors","volume":"5 3-4","pages":"90-99"},"PeriodicalIF":1.6,"publicationDate":"2019-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000495406","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37321356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
期刊
Gastrointestinal Tumors
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1